BACKGROUND: Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regar...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!